Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study

ConclusionsPatients initiating tocilizumab in routine practice had comparable effectiveness and safety outcomes regardless of whether they received tocilizumab as monotherapy or as combination therapy with csDMARDs.Trial RegistrationClinicalTrials.gov identifier, NCT01613378FundingF. Hoffmann-La Roche (Roche) Canada.

http://link.springer.com/10.1007/s40744-018-0130-6

Source: Rheumatology and Therapy - October 28, 2018 Category: Rheumatology Source Type: research